Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1989 Feb;102(1):93–103. doi: 10.1017/s0950268800029721

A norfloxacin dose finding study for selective decontamination of the digestive tract in pigs.

L A Van der Waaij 1, O Messerschmidt 1, D Van der Waaij 1
PMCID: PMC2249321  PMID: 2917619

Abstract

Five pigs were treated orally with norfloxacin for 5 consecutive days in two well-separated periods. This was done to determine the lowest dose required to free the pigs of Enterobacteriaceae. In the first period of the study, the animals were treated with 400 mg per day while in the second treatment 800 mg norfloxacin was given. Daily faecal culturing indicated that the faeces became free of Enterobacteriaceae in 3-5 days when treated with 400 mg/day, while all animals were found negative on culturing after 3 days of treatment with 800 mg/day. Investigation of the concentration of norfloxacin in the faeces revealed that a substantial fraction of the dose was either absorbed or inactivated by faecal substances. An in vitro study in faeces confirmed that a substantial part, some 75% of the dose, may have been inactivated by intestinal contents. This finding helps to explain the much lower concentration of 120 mg norfloxacin per kg of faeces in the pig in comparison with the almost tenfold higher concentration reported to develop in man during treatment with an identical dose.

Full text

PDF
93

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cofsky R. D., duBouchet L., Landesman S. H. Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers. Antimicrob Agents Chemother. 1984 Jul;26(1):110–111. doi: 10.1128/aac.26.1.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. De Vries-Hospers H. G., Welling G. W., Van der Waaij D. Norfloxacin for selective decontamination: a study in human volunteers. Prog Clin Biol Res. 1985;181:259–262. [PubMed] [Google Scholar]
  3. Drasar B. S., Jenkins D. J., Cummings J. H. The influence of a diet rich in wheat fibre on the human faecal flora. J Med Microbiol. 1976 Nov;9(4):423–431. doi: 10.1099/00222615-9-4-423. [DOI] [PubMed] [Google Scholar]
  4. Edlund C., Bergan T., Josefsson K., Solberg R., Nord C. E. Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics. Scand J Infect Dis. 1987;19(1):113–121. doi: 10.3109/00365548709032386. [DOI] [PubMed] [Google Scholar]
  5. Gilfillan E. C., Pelak B. A., Bland J. A., Malatesta P. F., Gadebusch H. H. Pharmacokinetic studies of norfloxacin in laboratory animals. Chemotherapy. 1984;30(5):288–296. doi: 10.1159/000238283. [DOI] [PubMed] [Google Scholar]
  6. Goldstein E. J., Citron D. M., Corrado M. L. Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract. Am J Med. 1987 Jun 26;82(6B):84–87. doi: 10.1016/0002-9343(87)90625-5. [DOI] [PubMed] [Google Scholar]
  7. Pecquet S. S., Andremont A. O., Tancrède C. H. Selective decontamination of the digestive tract by norfloxacin. A preliminary report. Prog Clin Biol Res. 1985;181:255–258. [PubMed] [Google Scholar]
  8. Sleijfer D. T., Mulder N. H., de Vries-Hospers H. G., Fidler V., Nieweg H. O., van der Waaij D., van Saene H. K. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer. 1980 Jun;16(6):859–869. doi: 10.1016/0014-2964(80)90140-1. [DOI] [PubMed] [Google Scholar]
  9. Stein G. E. Review of the bioavailability and pharmacokinetics of oral norfloxacin. Am J Med. 1987 Jun 26;82(6B):18–21. doi: 10.1016/0002-9343(87)90613-9. [DOI] [PubMed] [Google Scholar]
  10. Toorop-Bouma A. G., van der Waaij D. Trimethoprim used for selective decontamination of the digestive tract in rats: possible route of excretion. Scand J Infect Dis. 1987;19(3):361–367. doi: 10.3109/00365548709018483. [DOI] [PubMed] [Google Scholar]
  11. Veringa E. M., van der Waaij D. Biological inactivation by faeces of antimicrobial drugs applicable in selective decontamination of the digestive tract. J Antimicrob Chemother. 1984 Dec;14(6):605–612. doi: 10.1093/jac/14.6.605. [DOI] [PubMed] [Google Scholar]
  12. Winston D. J., Ho W. G., Champlin R. E., Karp J., Bartlett J., Finley R. S., Joshi J. H., Talbot G., Levitt L., Deresinski S. Norfloxacin for prevention of bacterial infections in granulocytopenic patients. Am J Med. 1987 Jun 26;82(6B):40–46. doi: 10.1016/0002-9343(87)90617-6. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES